Skip to main content
Clinical Trials/NCT05410262
NCT05410262
Completed
Not Applicable

Specific Mechanical Power Assessment in Patients With Acute Respiratory Distress Syndrome

Hospital El Cruce1 site in 1 country18 target enrollmentJuly 1, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Ventilation, Mechanical
Sponsor
Hospital El Cruce
Enrollment
18
Locations
1
Primary Endpoint
specific mechanical power
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

In ARDS patients, mechanical ventilation should minimize ventilator-induced lung injury. The mechanical power which is the energy per unit time released to the respiratory system according to the applied tidal volume, PEEP, respiratory rate, and flow should reflect the ventilator-induced lung injury

Detailed Description

Mechanical ventilation is an essential tool for the treatment of patients with acute respiratory distress syndrome (ARDS); however, as other strategies, it is not free of complications. Inadequate ventilation may have a negative impact on the lung that may eventually cause the development of multiple organ failure and death. This process is known as ventilator-induced lung injury (VILI). From a clinical perspective, one of the most important objectives of ARDS treatment is to avoid or mitigate the development of VILI, not only to preserve pulmonary integrity, but also to reduce mortality. Ventilator-induced lung injury results from the interaction between the mechanical load applied to the lung and its capacity to tolerate it. Factors such as tidal volume (Vt), plateau pressure (PPlat), lung strain or insufflation pressure (ΔP), inspiratory flow rate (VI), respiratory rate (RR), excessive inspiratory effort, high levels of FiO2 and high levels of positive end-expiratory pressure (PEEP), have been directly involved in damage mechanism. With an integrating and rheological idea, the concept of mechanical power tries to encompass the majority of these factors within a measurable unit in joules per minute, as the expression of power applied on a repetitive basis on the respiratory system in ARDS. Although the concept of MP holds promise for preventing the risk of VILI, its utility has not been proven in clinical practice until now. The main value of MP over the rest of commonly used variables for the monitoring of patients with ARDS is that it includes flow on injury mechanism (kinetic energy), accepting that an inverse relationship exists between this mechanism and the capacity of alveoli to adapt to change during the ventilation cycle (strain rate), as well as it embodies the concept of process repeatability (respiratory rate), though not of its duration. This begs the question whether we should consider its value at the moment of defining a mechanical ventilation strategy. The main disadvantage of its application is that MP conceives the respiratory system in an integrated manner and not related to or standardized with the ventilable lung portion, that is ultimately the one who has to withstand the ventilatory load; in other words, the same MP may have different consequences depending on the baby lung size or its equivalent, the severity of ARDS. The objective of this study is to evaluate the influence of the ventilable lung size on VILI mechanisms in patients suffering from ARDS treated with protective ventilation with similar MP.

Registry
clinicaltrials.gov
Start Date
July 1, 2022
End Date
December 30, 2022
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Hospital El Cruce
Responsible Party
Principal Investigator
Principal Investigator

Nestor Pistillo

Head of Intensive Care Unit al Hospital El Cruce

Hospital El Cruce

Eligibility Criteria

Inclusion Criteria

  • patients consecutively admitted with ARDS -

Exclusion Criteria

  • Patients who meet any of the following criteria: history of emphysema, asthma, pneumothorax or bronchopleural fistula. Severe instability condition at the time of the study: SaO2 ≤90%, shock requiring noradrenaline ≥0,5 γ/kg/min, ventricular arrhythmia, myocardial ischemia and endocranial hypertension. Esophageal pathology that contraindicates esophageal balloon placement. Severe coagulopathy (platelet count \<20000/mm3 or INR \>4). Inability to undergo CT imaging: morbid obesity (≥170 kg) or abdominal girth \>200 cm. Patients with do-not-resuscitate (DNR) orders, pregnant women and those who participated in other research studies within the last 30 days.

Outcomes

Primary Outcomes

specific mechanical power

Time Frame: "immediately after the intervention/procedure/surgery"

Specific mechanical power was calculated as the ratio of mechanical power to ventilable lung volume.

relationship between lung load and strain

Time Frame: "immediately after the intervention/procedure/surgery"

relationship between specific mechanical power and strain

relationship between lung load and atelectrauma

Time Frame: "immediately after the intervention/procedure/surgery"

relationship between specific mechanical power and atelectrauma

relationship between lung load and elastance of ARDS

Time Frame: "immediately after the intervention/procedure/surgery"

relationship between specific mechanical power and elastance of ARDS

relationship between lung load and severity of ARDS

Time Frame: "immediately after the intervention/procedure/surgery"

relationship between specific mechanical power and severity of ARDS

Study Sites (1)

Loading locations...

Similar Trials